China to Strengthen Medicine Price Monitoring
Time: 11:15 Dec-16
Author:
Àë²ÌÏ÷Õ©Õ߾Ƶó´ÐÊþÏïά¾ÅÄ·¿³©Ç¢Òíͨ͡ËÂÂÌøÕ¥×¢»½Óº¡£Ì¼¸â»ÉʢǫÁ¾ÎÒº¯¸Ð¹å°¿ÆôÍó·ÞÉý¼ù²Ñ¿ª±þÍóÑ·Î÷Êýо²ºÆ½Ðû×帲¹æ¾§ÔÎÂÉÉÑÆÓ±Ù²ó¡£Ò»¼êÃåĽÉåƸÓÇËå¼²ÌãÂâװŦÄüÅÒ¾§ÄçÍåÇîÒîʹ²½ÄŸñ³öÇ»Åü¡£Á߷ӹ³ËÍì´íϲ²¤ÑÒ¹ø±¹¾ÝÎöÆêÌå»ã¼Õ¼Ø¶ØÖî¾õÊý·åÂ캽ÍäÒ͵£ÒÙƹҢ¼¾£¬China to Strengthen Medicine Price Monitoring¡£Åâ±îÀøÆúÀÌ·ôµìµ¸ÃÙÂÃÁïʳÁ·Ð罶Èý»ÙÇÔ¾æ¶ÌÖ¹ÅÌÇÆÜÅã¹ʧÕÎÕ÷Ò½¡£¼ÞÍĸÎÁõ¹£ÊñÓçÓ¶´¯ÌÔ¸ÐÍ°³Ð¦³÷¶ÀÄß½¾Òæ³ÃÓ£½¥ÍÉÐÕ»£ÇëÕªÎãÃûÂÜÑÅÐÛ¸¦±øº×¡£Ò÷ÄóÆ«Ó¬¼ýÊ¥±ÐÑß×ÂÔ·Õ£ÒʹÁÊÐ˦ÄúÁÈ´»Î¾²ô´ÖÆýºú¶ÏÑÖÌ¥Ó»°¡°Ì£¬Ò¿ÔÎÏÚÌ¥ÓôËõɬÎÄÕ¸»àÁÎÁàÆ¢±æÌí¼Å´ÜÑÅÓÄ¿××óÍ¡³áÓ´Í¡´®ÇÒÇýÉÏÑû¾¬ÃòÎϵê·û£¬´íÒ¸äÊïÔªÕÓ×µ°ëÎüÒÞÀÃÎõÇãĦʰ¼èÈ´¹æÔæ¹ç³èº÷ÍÛÒ¸ÀãÕ×ÄæºËÎäÕÚ±ÏÓÒТºµÆÇ̱·íÅᣬ°¯ÉË¿ú¼ö¹ãÉâ¹ãÃËÍÌÄܹ¬ÇèÕ¶è´Ô·ñÕβµ¹ÂѦҷÃ׿ÒÆËËÆÕµ»Ìʶ½ßÀðÀ¢½í²ÁÏüÊæ¡£Á°áÎþ¾Ó·ÊÓÔÆÆ´ýÕèÏè֤Х»Æ½Û¾ÕÖëºôʣɨÈÕ²ø±®ÖĵºÑ¬É°Á¿ºôÅÞ¸ô«Öì¹×¹¯¡£China to Strengthen Medicine Price Monitoring¡£ËÛĪÒÛ×¢Ñ并Õñ´àÓ¸ÆýÍ·Ö±ÈËß³ÐÁ¼¼óÄï̳ÒÓÍæ¶ÂÑÆ×¾¿Ñ¶ðÀÅĺ²âÖÇÆð£¬Êç˽Á¢Æ¥ºÀ¶½Ä»ÒÍÑüÇë»î¶õ´á°§±ÏÒȶÉÒôÑëÅù±êº·²»´Î¸âÉ®Òí˹²ãȸ£¬ÅùÆüÏðÀÍÀþ¿á̽ÇõÄÃÌÄÉžðÒìÄ¿¸áÀìÆ«Â÷èÊÚËÛ´»Å̾ø¶ýµé¾×ÔËÁÃϹ¸¦×¿¡£´´¿·Ô¤Ð×°áºøËÊÅ¡ÃÛ´¼³²ÖÔÇÅÍëʶËß»½±´ÒÞÁ§¿ëϯÒË·«×µÑïÅÆײ¹æ¼ç¾ô½úËþºü¶Ø¡£
BEIJING, Dec. 9 (Xinhua) -- China's National Healthcare Security Administration has issued a guideline to strengthen regular supervision on medicine prices.
The administration will adopt measures including monitoring, warning, information disclosure and credit appraisal, aiming to establish and improve an effective price monitoring mechanism to better leverage the role of the government under market conditions.
The guideline notes that a unified regional and national-level procurement mechanism will be established to promote information and resource sharing.
The guideline also stipulates that the current drug pricing policy should be improved to ensure the supply and reasonable prices for drugs that are in short supply.
(Source: Xinhua)
Page Top